FCFelix S. Chew

Felix S. Chew

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Felix S. Chew has a total of 677 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Dynamic Ultrasound Imaging for Insertional Achilles Tendinopathy: A Cross‐Sectional Study

    by Giulio Cocco, Antonio Corvino, Andrea Delli Pizzi, Massimo Caulo, Giacomo Farì, Felix S. Chew, Vito Cantisani, Vincenzo Ricci

    Objectives: Recently, a novel dynamic maneuver in which the retrocalcaneal soft tissues are squeezed (CoRi sign) has been described for the diagnosis of partial tears involving the deep fibers of the Achilles tendon. This cross‐sectional study aims to assess the prevalence of the CoRi sign in a cohort of patients with a clinical diagnosis of IAT. Methods: A consecutive cohort of 58 patients (32 males, 26 females) seen at our institution with a clinical diagnosis of IAT comprised the study group for a cross‐sectional study to assess the prevalence of the CoRi sign in the study population and to correlate the findings on static B‐mode and color/power Doppler sonography with the CoRi dynamic maneuver. Results: The prevalence of CoRi sign was 15.5% in the study cohort (9/58) and 26.4% (9/34) in the subgroup of IAT patients with bursal effusion in B‐mode coupled with synovial hyperemia in color/power Doppler. Of the nine patients with a positive dynamic maneuver, eight of them presented insertional tendinosis with intratendinous hyperemia at color/power Doppler; in addition, none showed Achilles bone spurs of the calcaneal tuberosity. Lastly, four of the nine patients with a positive CoRi sign showed tendon–bone junction hyperemia in the absence of a bone spur. Conclusions: Tendon undersurface disruption in IAT patients is not uncommon, and dynamic ultrasound imaging is valuable for diagnosis. Hyperemic retrocalcaneal bursitis, insertional tendinosis with intratendinous hyperemia, and tendon–bone junction hyperemia are the most common static sonographic findings, respectively, in CoRi‐positive patients. Level of Evidence: Level IV—cross‐sectional study.

  • Open Access

    Supplementary Data from Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer

    by Elahe A. Mostaghel, Brett T. Marck, Orpheus Kolokythas, Felix Chew, Evan Y. Yu, Michael T. Schweizer, Heather H. Cheng, Phillip W. Kantoff, Steven P. Balk, Mary-Ellen Taplin, et al.

    Supplementary Fig 1-8, Supplementary Tables 1-4

  • Open Access

    Data from Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer

    by Elahe A. Mostaghel, Brett T. Marck, Orpheus Kolokythas, Felix Chew, Evan Y. Yu, Michael T. Schweizer, Heather H. Cheng, Phillip W. Kantoff, Steven P. Balk, Mary-Ellen Taplin, et al.

    Purpose:In metastatic castration-resistant prostate cancer (mCRPC) low serum androgens prior to starting abiraterone acetate (AA) is associated with more rapid progression. We evaluated the effect of AA on androgens in castration-resistant prostate cancer (CRPC) metastases and associations of intratumoral androgens with response.Experimental Design:We performed a phase II study of AA plus prednisone in mCRPC. The primary outcome was tissue testosterone at 4 weeks. Exploratory outcomes were association of steroid levels and genomic alterations with response, and escalating AA to 2,000 mg at progression.Results:Twenty-nine of 30 men were evaluable. Testosterone in metastatic biopsies became undetectable at 4 weeks (P < 0.001). Serum and tissue dehydroepiandrosterone sulfate (DHEAS) remained detectable in many patients and was not increased at progression. Serum and tissue DHEAS in the lowest quartile (pretreatment), serum DHEAS in the lowest quartile (4 weeks), and undetectable tissue DHEAS (on-therapy) associated with rapid progression (20 vs. 48 weeks, P = 0.0018; 20 vs. 52 weeks, P = 0.0003; 14 vs. 40 weeks, P = 0.0001; 20 vs. 56 weeks, P = 0.02, respectively). One of 16 men escalating to 2,000 mg had a 30% PSA decline; 13 developed radiographic progression by 12 weeks. Among patients with high serum DHEAS at baseline, wild-type (WT) PTEN status associated with longer response (61 vs. 33 weeks, P = 0.02).Conclusions:Low-circulating adrenal androgen levels are strongly associated with an androgen-poor tumor microenvironment and with poor response to AA. Patients with CRPC with higher serum DHEAS levels may benefit from dual androgen receptor (AR)-pathway inhibition, while those in the lowest quartile may require combinations with non–AR-directed therapy.

  • Beyond the Malleoli: Part 2—Avulsion Fractures of the Hindfoot

    by Kimia Kani, Derik L. Davis, Stephanie Jo, Felix S. Chew

    Avulsion fractures of the ankle and hindfoot are a diverse group of injuries occurring at level of retinacular, capsuloligamentous, and tendinous attachments. Accurate identification of avulsion fractures and their origins is based on understanding the relevant soft-tissue anatomy. In the first part of this two-series article, avulsion fractures at level of the ankle retinacula and distal tibiofibular syndesmosis were reviewed. The second part of this series of two articles is dedicated to reviewing the relevant anatomy, injury mechanisms, classification, nomenclature, imaging, treatment, and complications of hindfoot avulsion fractures occurring at level of the lateral ankle ligament complex (distally), posterior talar process, tendinous attachments, and miscellaneous soft-tissue attachments not otherwise specified.

  • Meniscal Allograft Transplantation: A Pictorial Review

    by Kimia Khalatbari Kani, Jack A. Porrino, Felix S. Chew


  • Paraneoplastic musculoskeletal disorders: review and update for radiologists

    by Kimia Khalatbari Kani, Jack A. Porrino, Michael E. Mulligan, Felix S. Chew

    Rheumatic paraneoplastic syndromes are rare syndromes that occur at distant sites from the underlying tumor and may involve the bones, joints, fasciae, muscles, or vessels. In the absence of a known tumor, early recognition of a rheumatic syndrome as paraneoplastic permits dedicated work-up for, and potentially early treatment of an occult malignancy. Although there is a continuously growing list of paraneoplastic rheumatic disorders, not all of these disorders have a well-established association with a neoplastic process. The goals of this article are to review the clinical characteristics, diagnostic work-up, and imaging findings of well-documented rheumatic paraneoplastic disorders.


  • Low-velocity, civilian firearm extremity injuries—review and update for radiologists

    by Kimia Khalatbari Kani, Jack A. Porrino, Felix S. Chew

    Firearm injuries are a preventable epidemic in the USA. Extremities are commonly affected in gunshot injuries. Such injuries may be complex with concomitant osseous, soft tissue, and neurovascular components. The maximum wounding potential of a projectile is determined by its kinetic energy and the proportion of the kinetic energy that is transmitted to the target. Accurate assessment of ballistic injuries is dependent on utilizing the principles of wound ballistics, accurate bullet count, and ballistic trajectory analysis. The goals of this article are to review wound ballistics and the imaging evaluation of extremity civilian firearm injuries in the adult population, with emphasis on ballistic trajectory analysis, specific ballistic fracture patterns, and diffuse, secondary soft tissue ballistic injuries.


  • Open Access

    Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer

    by Elahe A. Mostaghel, Brett T. Marck, Orpheus Kolokythas, Felix Chew, Evan Y. Yu, Michael T. Schweizer, Heather H. Cheng, Phillip W. Kantoff, Steven P. Balk, Mary-Ellen Taplin, et al.

    Purpose: In metastatic castration-resistant prostate cancer (mCRPC) low serum androgens prior to starting abiraterone acetate (AA) is associated with more rapid progression. We evaluated the effect of AA on androgens in castration-resistant prostate cancer (CRPC) metastases and associations of intratumoral androgens with response. Experimental Design: We performed a phase II study of AA plus prednisone in mCRPC. The primary outcome was tissue testosterone at 4 weeks. Exploratory outcomes were association of steroid levels and genomic alterations with response, and escalating AA to 2,000 mg at progression. Results: Twenty-nine of 30 men were evaluable. Testosterone in metastatic biopsies became undetectable at 4 weeks (P < 0.001). Serum and tissue dehydroepiandrosterone sulfate (DHEAS) remained detectable in many patients and was not increased at progression. Serum and tissue DHEAS in the lowest quartile (pretreatment), serum DHEAS in the lowest quartile (4 weeks), and undetectable tissue DHEAS (on-therapy) associated with rapid progression (20 vs. 48 weeks, P = 0.0018; 20 vs. 52 weeks, P = 0.0003; 14 vs. 40 weeks, P = 0.0001; 20 vs. 56 weeks, P = 0.02, respectively). One of 16 men escalating to 2,000 mg had a 30% PSA decline; 13 developed radiographic progression by 12 weeks. Among patients with high serum DHEAS at baseline, wild-type (WT) PTEN status associated with longer response (61 vs. 33 weeks, P = 0.02). Conclusions: Low-circulating adrenal androgen levels are strongly associated with an androgen-poor tumor microenvironment and with poor response to AA. Patients with CRPC with higher serum DHEAS levels may benefit from dual androgen receptor (AR)-pathway inhibition, while those in the lowest quartile may require combinations with non–AR-directed therapy.


  • Surgical techniques for management of acromioclavicular joint separations: review and update for radiologists

    by Kimia Khalatbari Kani, Jack A. Porrino, Hyojeong Mulcahy, Felix S. Chew

    Imaging plays a central role in the postoperative management of acromioclavicular (AC) joint separations. There are more than 150 described techniques for the surgical management of AC joint injuries. These procedures can be categorized as varying combinations of the following basic techniques: a) soft-tissue repair, b) trans-articular AC joint fixation, c) coracoclavicular (CC) fixation, d) non-anatomic reconstruction of the CC ligaments, e) anatomic reconstruction of the CC ligaments, f) distal clavicle resection, and g) dynamic muscle transfer. The goals of this article are to describe the basic techniques for the surgical management of AC joint separations with an emphasis on technique-specific complications and postoperative imaging assessment.